Form D Explorer

Inspect source fieldsReport a record issue

Form D — DNA SEQ 2, INC.

0002115201-26-000001 · filed Mar 11, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Pharmaceuticals filings

Offering

Industry
Pharmaceuticals
Exemptions
Rule 506(b)
Reported offering amount
$1,176,300
Reported amount sold
$1,176,300
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
DNA SEQ 2, INC.
CIK
2115201
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
1255 E VISTA WAY #157
VISTA, California 92084
Phone
585-987-2800

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗